Synthèse de glyconanovecteurs pour la thérapie photodynamique des cancers de la prostate

Synthèse de glyconanovecteurs pour la thérapie photodynamique des cancers de la prostate

Le récepteur du mannose 6-phosphate cation indépendant (RM6P-CI) permet l'endocytose puis le transfert de molécules porteuses du marqueur mannose 6-phosphate (M6P) vers les lysosomes. Le RM6P-CI, qui est surexprimé par les cellules de cancer de la prostate, est une cible de choix pour augmenter...

Full description

Bibliographic Details
Main Author:	Bouffard, Elise
Other Authors:	Montpellier 2
Language:	fr
Published:	2014
Subjects:	Glyconanovecteurs Ciblage Cancers de la prostate Glyconanovectors Targeting Prostate cancer
Online Access:	http://www.theses.fr/2014MON20231

Similar Items

Développement d'un oligonucléotide antisense lipid modifié anti TCTP, dans le traitement des cancers de la prostate résistants à la thérapie
by: Karaki, Sara
Published: (2016)

Récepteur du mannose-6-phosphate : applications pour le diagnostic et la thérapie photodynamique des cancers de la prostate
by: Vaillant, Ophélie
Published: (2013)

Synthèse chimique et activité biologique d'une série de dérivés amides en position 7α de la testostérone
by: Morin, Nathalie
Published: (2012)

Focal therapy for prostate cancer: The current status
by: Susan Marshall, et al.
Published: (2015-06-01)

Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
by: Asta Juzeniene, et al.
Published: (2021-02-01)

The Microbiome of Prostate Fluid Is Associated With Prostate Cancer
by: Xiaowei Ma, et al.
Published: (2019-07-01)

Do not underestimate anterior prostate cancer
by: Sarka Kudlackova, et al.
Published: (2021-06-01)

Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database
by: Nikola Cihoric, et al.
Published: (2018-06-01)

PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
by: Mohamed El Fakiri, et al.
Published: (2021-08-01)

An improbable trifecta: Occurrence of xanthogranulomatous prostatitis, prostate cancer, and prostatic abscess in a single patient
by: Jonathan Demeter, et al.
Published: (2021-03-01)

THE ROLE OF CHRONIC PROSTATITIS IN THE PATHOGENESIS OF PROSTATE CANCER
by: A. S. Pere
Published: (2014-07-01)

THE ROLE OF CHRONIC PROSTATITIS IN THE PATHOGENESIS OF PROSTATE CANCER
by: A. S. Pere
Published: (2014-07-01)

Neuroendocrine and Aggressive-Variant Prostate Cancer
by: Nicholas Spetsieris, et al.
Published: (2020-12-01)

Conception, élaboration et caractérisation photophysiques et biochimiques de molécules photoactivables pour la thérapie photodynamique
by: Verhille, Marc
Published: (2012)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
by: Rodolfo Montironi, et al.
Published: (2020-04-01)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
by: Sung Han Kim, et al.
Published: (2021-04-01)

Primary metastatic prostate cancer between prognosis or adequate/proper medical therapy
by: Mahmoud Mustafa, et al.
Published: (2021-01-01)

Targeted nonviral gene therapy in prostate cancer
by: Altwaijry N, et al.
Published: (2018-09-01)

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
by: Xueqing Cheng, et al.
Published: (2021-02-01)

Synthèse de nouveaux dérivés osidiques pour le ciblage de lectines originales
by: Bibi, Rashda
Published: (2012)

Association of prostate volume with incidence and aggressiveness of prostate cancer
by: Al-Khalil S, et al.
Published: (2016-10-01)

The biology of photodynamic therapy in the bladder and prostate
by: Chang, Stanley Shi-Chung
Published: (1996)

Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy
by: Yoshiyasu Amiya, et al.
Published: (2015-03-01)

Phage Therapy in Prostatitis: Recent Prospects
by: Andrzej Górski, et al.
Published: (2018-06-01)

Moving ahead of prostate-specific antigen
by: Banyameen Mohamad Iqbal, et al.
Published: (2016-01-01)

Paysage immunologique du cancer de la prostate
by: Molina, Oscar Eduardo
Published: (2021)

The role of targeted biopsy methods in the prostate cancer diagnosis
by: V. S. Petov, et al.
Published: (2021-07-01)

Effectiveness of magnetic resonance imaging–targeted biopsy for detection of prostate cancer in comparison with systematic biopsy in our countries with low prevalence of prostate cancer: our first experience after 3 years
by: Mostafa A. Arafa, et al.
Published: (2021-09-01)

The results of transrectal prostate biopsy in patients with low levels of prostate specific antigen
by: Ahmet Ali Sancaktutar, et al.
Published: (2012-06-01)

Temporal Changes in Prostate Biopsy Use in Ontario
by: Lavallée, Luke Thomas
Published: (2016)

Monitoring de dose pour la radiothérapie du cancer de la prostate
by: Nassef, Mohamed
Published: (2016)

POSSIBILITIES OF RADIUM-223 APPLICATION IN THERAPY OF PROSTATE GLAND CANCER
by: A. A. GRITSKEVICH, et al.
Published: (2017-06-01)

Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review
by: Marco Randazzo, et al.
Published: (2018-12-01)

The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients
by: A. W. Postema, et al.
Published: (2017-04-01)

Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01)

The Relation among Prostate Cancer Knowledge and Psychosocial Factors for Prostate Cancer Screening among African American Men: a Correlational Study
by: Sabrina L. Dickey, et al.
Published: (2017-10-01)

Possibility of using PCA3 score without prostate massage in urine for diagnosing prostate cancer
by: A. A. Musaelyan, et al.
Published: (2021-02-01)

Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation
by: Heikki Seikkula, et al.
Published: (2020-03-01)

The Management of Patients Diagnosed with Incidental Prostate Cancer: Narrative Review
by: Abedi AR, et al.
Published: (2020-03-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)